The Hawaii State Department of Health (HDOH) has released its 2013 annual report describing healthcare-associated infections (HAIs) among patients treated in Hawaii’s acute-care facilities.
The report provides data reported for the following HAIs: central line-associated bloodstream infections (CLABSI), catheter-associated urinary tract infections (CAUTI) in intensive care units (ICU), and all inpatient surgical site infections (SSI) for abdominal hysterectomies and colon surgeries. The report also presents data on the occurrence of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia, Clostridium difficile infections (CDI), and healthcare personnel influenza vaccinations. The report indicates Hawaii acute-care facilities are showing improvement when compared to national data.
Source: CDC
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.